
Turnkey centers will promote scalable vaccine production for an end-to-end manufacturing network for mRNA-based vaccines in Africa
Turnkey centers will promote scalable vaccine production for an end-to-end manufacturing network for mRNA-based vaccines in Africa
CDMO obtains both Vibalogics and Arranta Bio to increase presence in the sector
Will establish presence in Belgium, Denmark, Norway, the Netherlands, Poland and Sweden
Plans are underway to build Scottish fill-finish center, renovate API facility in England
The solution is a combination of cold chain logistics, serialization compliance and distribution
With the deal, the China-based CDMO grows its US presence
Anticipated yearly production is 2 million units
Newly acquired Performance Cell Manufacturing will now be known as Cellipont Bioservices
CDMO's new South Korean facility to offer a range of production services
Acquisition of AcKnowledge RS also expands company's IVD expertise
Will welcome seven temperature-controlled processing suites to accommodate various biologic drug needs
Partnership enhances CBM’s manufacturing capabilities in C> space
Agreement allows CRO to grow its manufacturing services, including in the chemistry space
Marks the first step in two-phase facility expansion project
Center’s 89,000 square-foot expansion expected to double its capacity
Strategic collaboration will feature Mammoth’s CRISPR know-how to design in vivo therapies
Collaboration aims to prioritize best practices in fields of biopreservation and closed-system manufacturing, while improving children’s health
The shot—which could be the first one to be mRNA based—is scheduled to begin clinical trials later this year
Investment features the construction of a high-throughput screening center
BFS technology deal expected to be finalized in Q1
ABC’s new acquisition, FirstView Financial, addresses underpayment of pharmacies, as well as patient assistance programs
Pharma firms—not only in Europe but in the US as well—are continuously looking for alternative supply channels inside their respective blocks
The $17.4-billion deal, CDMO says, will help expand its offerings in the clinical development space
Site is located in the state of Gujarat, a major hub for pharma logistics
CDMO’s financial commitment will feature construction of a new GMP clinical trial development facility